Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019030422) USE OF LEVOTHYROXINE FOR THE TREATMENT OF DIABETES MELLITUS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/030422 International Application No.: PCT/ES2018/070552
Publication Date: 14.02.2019 International Filing Date: 09.08.2018
IPC:
A61K 31/198 (2006.01) ,A61P 3/10 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
195
having an amino group
197
the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid
198
Alpha-amino acids, e.g. alanine, edetic acid (EDTA)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
Applicants:
FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD [ES/ES]; Avda. Américo Vespucio, nº 15, Edificio S-2 41092 Sevilla, ES
Inventors:
MARTÍN-MONTALVO SÁNCHEZ, Alejandro; ES
GAUTHIER, Benoit Raymond; ES
LÓPEZ-NORIEGA, Livia; ES
COBO VUILLEUMIER, Nadia; ES
Agent:
FUSTER, Gustavo; ES
Priority Data:
P20173103111.08.2017ES
Title (EN) USE OF LEVOTHYROXINE FOR THE TREATMENT OF DIABETES MELLITUS
(FR) UTILISATION DE LÉVOTHYROXINE POUR LE TRAITEMENT DU DIABÈTE SUCRÉ
(ES) USO DE LEVOTIROXINA PARA EL TRATAMIENTO DE LA DIABETES MELLITUS
Abstract:
(EN) The present invention relates to the use of levothyroxine in the treatment of diabetes mellitus, especially diabetes mellitus type 1.
(FR) La présente invention concerne l'utilisation de lévothyroxine dans le traitement du diabète sucré, en particulier le diabète de type 1.
(ES) La presente invención se refiere al uso de Levotiroxina, en el tratamiento de la diabetes mellitus, particularmente diabetes mellitus tipo 1.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Spanish (ES)
Filing Language: Spanish (ES)